Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

4 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Achieving clinical outcomes with benralizumab in severe eosinophilic asthma patients in a real-world setting: orbe II study.
Padilla-Galo A, Moya Carmona I, Ausín P, Carazo Fernández L, García-Moguel I, Velasco-Garrido JL, Andújar-Espinosa R, Casas-Maldonado F, Martínez-Moragón E, Martínez Rivera C, Vera Solsona E, Sánchez-Toril López F, Trisán Alonso A, Blanco Aparicio M, Valverde-Monge M, Valencia Azcona B, Palop Cervera M, Nuevo J, Sánchez Tena J, Resler G, Luzón E, Levy Naon A. Padilla-Galo A, et al. Among authors: moya carmona i. Respir Res. 2023 Sep 28;24(1):235. doi: 10.1186/s12931-023-02539-7. Respir Res. 2023. PMID: 37770889 Free PMC article.
Real-life cost-effectiveness of benralizumab in patients with severe asthma.
Padilla-Galo A, García-Ruiz AJ, Levy Abitbol RC, Olveira C, Rivas-Ruiz F, García-Agua Soler N, Pérez Morales M, Valencia Azcona B, Tortajada-Goitia B, Moya-Carmona I, Levy-Naon A. Padilla-Galo A, et al. Among authors: moya carmona i. Respir Res. 2021 May 27;22(1):163. doi: 10.1186/s12931-021-01758-0. Respir Res. 2021. PMID: 34044819 Free PMC article.
Real-life experience with benralizumab during 6 months.
Padilla-Galo A, Levy-Abitbol R, Olveira C, Valencia Azcona B, Pérez Morales M, Rivas-Ruiz F, Tortajada-Goitia B, Moya-Carmona I, Levy-Naon A. Padilla-Galo A, et al. Among authors: moya carmona i. BMC Pulm Med. 2020 Jun 29;20(1):184. doi: 10.1186/s12890-020-01220-9. BMC Pulm Med. 2020. PMID: 32600318 Free PMC article.
Assessing Pharmacists' Preferences towards Efficacy Attributes of Disease-Modifying Therapies in Relapsing-Remitting Multiple Sclerosis.
Martínez-López I, Maurino J, Sanmartín-Fenollera P, Ontañon-Nasarre A, Santiago-Pérez A, Moya-Carmona I, García-Collado CG, Fernández-Del Olmo R, García-Arcelay E, Sarmiento M, Carreño Á, Pérez-Encinas M. Martínez-López I, et al. Among authors: moya carmona i. Pharmacy (Basel). 2020 Apr 7;8(2):61. doi: 10.3390/pharmacy8020061. Pharmacy (Basel). 2020. PMID: 32272683 Free PMC article.